Photo from wikipedia
This bayesian reanalysis of a previous meta-analysis of 15 randomized clinical trials evaluates whether treatment with tocilizumab was associated with meaningful mortality benefit among hospitalized patients with COVID-19. Click to show full abstract
This bayesian reanalysis of a previous meta-analysis of 15 randomized clinical trials evaluates whether treatment with tocilizumab was associated with meaningful mortality benefit among hospitalized patients with COVID-19.
Keywords:
hospitalized patients;
mortality rates;
rates among;
patients covid;
among hospitalized
Journal Title: JAMA Network Open
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: JAMA Network Open
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!